Literature DB >> 34598101

Claims-based measures of prescription opioid utilization: A practical guide for researchers.

Sara E Heins1, Christine Buttorff2, Courtney Armstrong3, Rosalie Liccardo Pacula4.   

Abstract

BACKGROUND: Given the increased attention to the opioid epidemic and the role of inappropriate prescribing, there has been a marked increase in the number of studies using claims data to study opioid use and policies designed to curb misuse. Our objective is to review the medical literature for recent studies that use claims data to construct opioid use measures and to develop a guide for researchers using these measures.
METHODS: We searched for articles relating to opioid use measured in health insurance claims data using a defined set of search terms for the years 2014-2020. Original research articles based in the United States that used claims-based measures of opioid utilization were included and information on the study population and measures of any opioid use, quantity of opioid use, new opioid use, chronic opioid use, multiple providers, and overlapping prescriptions was abstracted.
RESULTS: A total of 164 articles met inclusion criteria. Any opioid use was the most commonly included measure, defined by 85 studies. This was followed by quantity of opioids (68 studies), chronic opioid use (53 studies), overlapping prescriptions (28 studies), and multiple providers (8 studies). Each measure contained multiple, distinct definitions with considerable variation in how each was operationalized.
CONCLUSIONS: Claims-based opioid utilization measures are commonly used in research, but definitions vary significantly from study to study. Researchers should carefully consider which opioid utilization measures and definitions are most appropriate for their study and recognize how different definitions may influence study results.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Claims data; Opioids; Prescription data

Mesh:

Substances:

Year:  2021        PMID: 34598101      PMCID: PMC8595838          DOI: 10.1016/j.drugalcdep.2021.109087

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  80 in total

1.  Postoperative Opioid Prescribing and the Pain Scores on Hospital Consumer Assessment of Healthcare Providers and Systems Survey.

Authors:  Jay S Lee; Hsou M Hu; Chad M Brummett; John D Syrjamaki; James M Dupree; Michael J Englesbe; Jennifer F Waljee
Journal:  JAMA       Date:  2017-05-16       Impact factor: 56.272

Review 2.  Measures to quantify the abuse of prescription opioids: a review of data sources and metrics.

Authors:  Alex M Secora; Catherine M Dormitzer; Judy A Staffa; Gerald J Dal Pan
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-09-25       Impact factor: 2.890

3.  Opioid dose and drug-related mortality in patients with nonmalignant pain.

Authors:  Tara Gomes; Muhammad M Mamdani; Irfan A Dhalla; J Michael Paterson; David N Juurlink
Journal:  Arch Intern Med       Date:  2011-04-11

4.  Prevalence of Opioid and Benzodiazepine Prescriptions for Osteoarthritis.

Authors:  Vignesh K Alamanda; Meghan K Wally; Rachel B Seymour; Bryan D Springer; Joseph R Hsu
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-05-25       Impact factor: 4.794

5.  Prescription practices involving opioid analgesics among Americans with Medicaid, 2010.

Authors:  Karin A Mack; Kun Zhang; Leonard Paulozzi; Christopher Jones
Journal:  J Health Care Poor Underserved       Date:  2015-02

Review 6.  Defining Nonmedical Use of Prescription Opioids Within Health Care Claims: A Systematic Review.

Authors:  Gerald Cochran; Bongki Woo; Wei-Hsuan Lo-Ciganic; Adam J Gordon; Julie M Donohue; Walid F Gellad
Journal:  Subst Abus       Date:  2015-02-11       Impact factor: 3.716

7.  All-Cause and Drug-Related Medical Events Associated with Overuse of Gabapentin and/or Opioid Medications: A Retrospective Cohort Analysis of a Commercially Insured US Population.

Authors:  Alyssa M Peckham; Kathleen A Fairman; David A Sclar
Journal:  Drug Saf       Date:  2018-02       Impact factor: 5.606

8.  The Concentration of Opioid Prescriptions by Providers and Among Patients in the Oregon Medicaid Program.

Authors:  Hyunjee Kim; Daniel M Hartung; Reside L Jacob; Dennis McCarty; K John McConnell
Journal:  Psychiatr Serv       Date:  2016-01-14       Impact factor: 3.084

Review 9.  The state of the science in opioid policy research.

Authors:  Megan S Schuler; Sara E Heins; Rosanna Smart; Beth Ann Griffin; David Powell; Elizabeth A Stuart; Bryce Pardo; Sierra Smucker; Stephen W Patrick; Rosalie Liccardo Pacula; Bradley D Stein
Journal:  Drug Alcohol Depend       Date:  2020-06-27       Impact factor: 4.492

10.  A Systematic Review of Laboratory Evidence for the Abuse Potential of Tramadol in Humans.

Authors:  Kelly E Dunn; Cecilia L Bergeria; Andrew S Huhn; Eric C Strain
Journal:  Front Psychiatry       Date:  2019-09-26       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.